China Pharma Holdings (CPHI) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on China Pharma Holdings (CPHI) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.10 of bullish evidence against -0.45 bearish.

China Pharma Holdings last closed at $0.87, -9.37% on the session.

Against the IVW growth benchmark the position is -10.17% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

20 graded predictions for CPHI so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks China Pharma Holdings in the 28th percentile on return on equity, where 100 is best.

China Pharma Holdings is classified under Health Care / Pharmaceuticals, with a market capitalisation of $41.30M.

StockMap tracks China Pharma Holdings as the 116th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite China Pharma Holdings ranks 106th of 151 in the group, against a group median of -0.08.